DIANA LUCKHARDT: Open Payments
NPI 1760767040 · IONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 29 payments from 18 companies in 2025. Trend: 2023 $584 · 2024 $920 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $151 |
| Calliditas Therapeutics US Inc. | 3 | $109 |
| Amgen Inc. | 5 | $93 |
| Chiesi USA, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $33 |
| Novo Nordisk Inc | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| CorMedix Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
Products named: Vanrafia, TARPEYO, TAVNEOS, ELFABRIO, JARDIANCE, Fabhalta, VOYXACT, Ozempic.
Industry payments across MI — which companies pay providers there.
